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Correspondence Eroding the DenominatorThe Incomplete Story of Door-to-Balloon Time Reporting
P
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MTo the Editor: Door-to-balloon time (DTB) is the focus of national
uidelines, and intense efforts to reduce it have been a core
omponent of many national quality improvement campaigns.
ecently, it has been the high point of advertisement campaigns by
ospital systems and ultimately might be used to reward perfor-
ance by payers. It is now publicly reported by the Centers for
edicare & Medicaid Services and the U.S. Department of Health
nd Human Services, allowing patients to compare hospitals for care
f acute myocardial infarction with an online resource (1).
Given its emerging importance, it is important to assess how
this measure is tracked nationally. Recently, Ellis et al. (2)
introduced the “weasel clause” to highlight a number of new
exclusions that result in an unknown number of patients to be
systematically omitted from institutional reporting for reasons
never accounted for in the seminal studies defining the importance
of this measure (3). Specifically, these exclusions relate to “non-
system”-based delays involving patients with difficult vascular access,
delay in consent to procedure, need for intubation/cardiac arrest, and
where the culprit lesion was difficult to cross. The goal of our report
is to assess the prevalence of the proportion of patients who are thus
excluded and describe their clinical outcomes.
We used the Blue Cross and Blue Shield of Michigan Cardio-
vascular Consortium database to evaluate the outcome of all
patients undergoing primary percutaneous coronary intervention
(PCI) for ST-segment elevation myocardial infarction in Michigan in
2010. The details of this registry have been previously published (4).
A total of 2,463 patients underwent primary PCI in 2010 at the
3 hospitals that participate in the Blue Cross and Blue Shield of
ichigan Cardiovascular Consortium. Of these patients, 2,004
ere eligible for reporting DTB data, whereas 447 (18.1%) would
e excluded from reporting with the “weasel clause.” The main
easons for exclusion were development of cardiac arrest/need for
ntubation (7.8%, n  191) and other causes (6.4%, n  157),
whereas difficulty in crossing the lesion (2.1%, n  51), difficulty
btaining vascular access (1.2%, n  30), and difficulty in obtain-
ng consent (0.7%, n  18) accounted for the remainder. Median
TB in those with difficult vascular access was 93 min, 93.5 min
or those patients with cardiac arrest or need for intubation, 104
in in those with difficulty crossing the lesion, 104.5 min in
other” delays, and 142.5 min in those with delays obtaining
onsent. Median DTB for those without system delay for PCI was
8 min.
Of the study cohort, 150 patients died before hospital discharge.
f these deaths, 56% (n  84) would be excluded from consid-
ration by American College of Cardiology/National Cardiovas-
ular Data Registry criteria. The vast majority (44% of all deaths,
 66) were among those patients presenting with cardiac arrest
r requiring intubation. Of all the 150 in-hospital deaths,
.3% (n 5) would be excluded for operator difficulty crossing thelesion, 0.7% (n  1) would be excluded for operator difficulty tgaining vascular access, and 0.7% (n  1) would be excluded for
delay in obtaining consent from the patient. Finally, 7.3% (n 11)
of in-hospital deaths would be excluded from reporting for “other”
non-system delays. In comparison, only 44% of all deaths (n 66)
were outside of the current parameters for exclusion and thus
eligible for DTB reporting (Fig. 1).
These findings highlight the need to strongly reconsider the
implications of the “weasel clause” in relation to the reporting of
DTB. The results from our study would suggest that our quality
improvement efforts, if developed in response to the data as
reported, would miss more than one-half of the patients who end
up dying from ST-segment elevation myocardial infarction.
Exclusions for reporting serve a dual purpose in allowing for fair
comparisons between centers with potentially disparate patient
populations as well as encouraging broad use of lifesaving services.
For example, by eliminating patients with extreme characteristics
or risk, exclusions allow a large volume center to be compared with
a smaller one. Similarly, exclusion of higher-risk patients (with
much higher probability of worsened outcome at presentation)
encourages centers to offer therapies and interventions that might
be withheld if their outcome were “reportable.” However, as our
data show, this medical moral hazard might be obscuring the
current drivers of in-hospital mortality instead of helping focus
attention on them. A key consideration for the future will be to
dissociate these measures of performance from reimbursement, so
as to allow for comprehensive reporting and data collection
without the threat of punishment.
Efforts to ensure a level playing field and minimize the negative
impact of public reporting should not distract from the most
important goal—reducing mortality and ensuring the optimal
outcome for our patients.
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